The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance

KDM4/JMJD2 are H3K9- and H3K36-specific demethylases, which are considered promising therapeutic targets for the treatment of acute myeloid leukemia (AML) harboring MLL translocations. Here, we investigate the long-term effects of depleting KDM4 activity on normal hematopoiesis to probe potential si...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood
Auteurs principaux: Agger, Karl, Nishimura, Koutarou, Miyagi, Satoru, Messling, Jan-Erik, Rasmussen, Kasper Dindler, Helin, Kristian
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2019
Sujets:
Hematopoiesis and Stem Cells
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6776794/
https://ncbi.nlm.nih.gov/pubmed/31434704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019000855
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires